天然产物研究与开发 ›› 2026, Vol. 38 ›› Issue (7): 1428-1437.doi: 10.16333/j.1001-6880.2026.7.005 cstr: 32307.14.1001-6880.2026.7.005

• 研究论文 • 上一篇    下一篇

石菖蒲挥发油通过TNF/NF-κB/NLRP3通路抑制小胶质细胞极化抗抑郁的作用研究

郑甜甜1,张惠钰1,曹宇宇1,吕博洋1,刘思琦2,谭娟娟3,杨洪义3*   

  1. 1陕西中医药大学医学技术学院;2陕西中医药大学针灸推拿学院;3陕西中医药大学整合医学研究院,咸阳 712046
  • 出版日期:2026-07-24 发布日期:2026-07-23
  • 基金资助:
    陕西省科技厅自然科学基础研究计划一般项目(2025JC-YBMS-1034);陕西省教育厅科研计划重点实验室项目(22JS006);陕西省科技厅自然科学基础研究计划一般项目(2023-JC-QN-0853)

Antidepressant mechanism of Acorus tatarinowii volatile oil via inhibition of microglial polarization through the TNF/NF-κB/NLRP3 signaling pathway

ZHENG Tian-tian1,ZHANG Hui-yu1,CAO Yu-yu1,LYU Bo-yang1,LIU Si-qi2,TAN Juan-juan3,YANG Hong-yi3*   

  1. 1College of Medical Technology,Shaanxi University of Chinese Medicine;2College of Acupuncture and Tuina, Shaanxi University of Chinese Medicine;3Institute of Integrative Medicine, Shaanxi University of Chinese Medicine, Xianyang 712046,China
  • Online:2026-07-24 Published:2026-07-23

摘要:

聚焦炎症信号通路与小胶质细胞极化的调控关系,探究石菖蒲挥发油(volatile oil of Acorus tatarinowii,VOA)的抗抑郁作用及免疫学机制。雄性ICR小鼠随机分为对照组、模型组、氟西汀阳性药组及VOA低、中、高剂量组,VOA吸嗅给药,腹腔注射脂多糖(lipopolysaccharide,LPS)建立抑郁模型。通过转录组测序筛选差异表达基因并进行通路富集分析,采用Western blot检测小鼠海马组织肿瘤坏死因子(tumor necrosis factor,TNF)/核因子kappa B (nuclear factor kappa B,NF‑κB)/核苷酸结合寡聚化结构域样受体蛋白3(NOD-like receptor protein 3,NLRP3)通路关键蛋白及小胶质细胞M1/M2表型标志物CD16/32和CD206的表达水平。体外实验以LPS活化的BV‑2小胶质细胞为研究对象,采用CCK‑8法检测细胞存活率、筛选药物适宜浓度,Griess法检测细胞上清液一氧化氮(NO)释放量,Western blot测定p‑NF‑κB p65/NF‑κB p65蛋白表达比值。结果显示,VOA调控的差异基因主要富集于TNF、白细胞介素1β(interleukin-1βIL-1β)、趋化因子C-C基元配体2(chemokine C-C motif ligand 2,CCL2前列素内环氧化物合成酶2(prostaglandin endoperoxide synthase 2,PTGS2NLRP3等炎症相关靶点,其抗抑郁作用与TNF介导的炎症信号通路密切相关。与模型组比较,VOA各剂量组小鼠海马组织CD16/32及TNF/NF‑κB/NLRP3通路相关蛋白表达显著降低,CD206表达明显升高(P<0.05)。体外实验证实,VOA可呈剂量依赖性减轻LPS介导的BV-2细胞损伤,抑制LPS诱导的BV‑2细胞活化,减少NO释放,并显著下调p‑NF‑κB p65/NF‑κB p65比值(P<0.05)。综上所述,VOA可通过下调TNF/NF‑κB/NLRP3信号通路,抑制小胶质细胞M1型极化、促进M2型转化,减轻中枢神经炎症,进而发挥抗抑郁作用。

关键词: 石菖蒲挥发油, 抑郁症, TNF/NF-κB/NLRP3信号通路, 小胶质细胞, 神经炎症

Abstract:

This study focused on the regulatory relationship between inflammatory signaling pathways and microglial polarization, aiming to clarify the antidepressant effect and immunological mechanism of volatile oil of Acorus tatarinowii (VOA). In in vivo experiments, male ICR mice were randomly divided into control group, model group, fluoxetine hydrochloride positive control group, and VOA low-, medium-, and high-dose groups. VOA was administered by intranasal inhalation, and lipopolysaccharide (LPS) was intraperitoneal injected to establish the depression model. Transcriptome sequencing was used to screen key differentially expressed genes related to the antidepressant effect of VOA and perform pathway enrichment analysis. Meanwhile, Western blot was employed to detect the expression levels of proteins related to the tumor necrosis factor/nuclear factor kappa B/NOD-like receptor protein 3 (TNF/NF-κB/NLRP3) pathway and microglial M1/M2 phenotypic markers CD16/32 and CD206 in mouse hippocampus. In vitro experiments were performed using LPS-activated BV‑2 microglia. The cell survival rate was detected by CCK‑8 assay and the optimal drug concentration was screened, nitric oxide (NO) release in the cell supernatant was detected by the Griess method, and the protein expression ratio of p‑NF‑κB p65/NF‑κB p65 was determined by Western blot. The results showed that differentially expressed genes regulated by VOA were mainly enriched in inflammation‑related targets such as TNF, interleukin‑1β (IL-1β), chemokine (C‑C motif) ligand 2 (CCL2), prostaglandin endoperoxide synthase 2 (PTGS2), and NLRP3, and the antidepressant effect of VOA was closely related to the TNF-mediated inflammatory signaling pathway. Compared with the model group, the expression levels of M1-type microglial marker CD16/32 protein and proteins related to the TNF/NF-κB/NLRP3 pathway in the hippocampal tissue of mice in each VOA dose group were significantly decreased, while the expression level of M2-type marker CD206 protein was significantly increased (P<0.05). In vitro experiments confirmed that VOA could dose-dependently protect BV-2 cell against LPS-induced injury, inhibit LPS-induced activation of BV-2 microglia, reduce NO release (P<0.05), and significantly downregulate the expression ratio of p-NF-κB p65/NF-κB p65 protein (P<0.05). In conclusion, VOA can inhibit microglial M1 polarization, promote M2 transformation, and alleviate central nervous inflammation by downregulating the TNF/NF‑κB/NLRP3 signaling pathway, thereby exerting an antidepressant effect.

Key words:  Acorus tatarinowii volatile oil, depression, TNF/NF-κB/NLRP3 signaling pathway, microglia, neuroinflammation

中图分类号:  R285 R964